Troculeucel, a cryopreserved, autologous enhanced natural killer cell therapy, has demonstrated preliminary clinical benefit without any drug-related adverse events in two Phase I clinical trials in ...

A new study published in the journal Progress in Neuro-Psychopharmacology and Biological Psychiatry found that cannabidiol ...

Melatonin is wildly popular—and wildly misunderstood. Here’s why scientists say taking this supplement doesn’t necessarily ...

Cannabis advocates will hold a mass rally at the Ministry of Public Health on Monday to protest the government's campaign to recriminalise the plant three years after it was removed from the national ...

A new Stanford Medicine study reveals a promising approach to slowing Parkinson's disease by targeting overactive LRRK2 enzymes with an MLi-2 inhibitor, showing neuron restoration in mice.

Research shows promising results for a weekly injectable Parkinson's treatment that maintains consistent medication levels, possibly eliminating multiple daily pills.

Research shows promising results for a weekly injectable Parkinson's treatment that maintains consistent medication levels, possibly eliminating multiple daily pills.

If the link between Parkinson's disease and the virus is proven, this might help find a way to slow the progression of Parkinson's.

Researchers now have a powerful new way to understand the types of brain cells that are affected in neurodegenerative diseases and to uncover connections between conditions such as Parkinson's ...

Blocking an enzyme in mice restored a key protector of neurons, signaling hope for biotechs pursuing the pathway in Parkinson’s ...

A Brazilian physical therapist has been leading a unique project in Rio de Janeiro since 2018, trying to help patients with Parkinson's disease with capoeira classes. It's a movement practice that ...